In general, men on ADT, particularly those on a GnRH, were older at the time of prostate cancer diagnosis, had more locally advanced cancer, higher serum PSA levels and higher proportion of nodal and distant metastases compared with men not on ADT (Table 1). This evidence concerns the gene GNRH1 and prostate cancer.